Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2550]

EMCTO 2013: Meta-analysis slightly favours platinum-based first-line treatment in patients with advanced/metastatic NSCLC

EMCTO 2013: Meta-analysis slightly favours platinum-based first-line treatment in patients with advanced...

EMCTO 2013: A study of simultaneous occurrence of EGFR mutations and HER2 gene amplifications in large series of NSCLC

EMCTO 2013: A study of simultaneous occurrence of EGFR mutations and HER2 gene amplifications in large series of...

EMCTO 2013: First-line gefitinib effective and well tolerated in Caucasian patients with EGFR mutation-positive NSCLC

EMCTO 2013: First-line gefitinib effective and well tolerated in Caucasian patients with EGFR mutation-positive...

EMCTO 2013: Enobosarm improves muscle wasting experienced by patients with NSCLC

EMCTO 2013: Enobosarm improves muscle wasting experienced by patients with NSCLC

EMCTO 2013: Findings support the value of tumour rebiopsy in NSCLC patients

EMCTO 2013: Findings support the value of tumour rebiopsy in NSCLC patients

Chemo, radiation followed by surgery improves survival in lung cancer patients

Chemo, radiation followed by surgery improves survival in lung cancer patients

Diabetes drug makes lung cancer vulnerable to radiotherapy

Diabetes drug makes lung cancer vulnerable to radiotherapy

Latin America risks being “overwhelmed” by burgeoning cancer epidemic

Latin America risks being “overwhelmed” by burgeoning cancer epidemic

ESTRO 2013: Commonly used drug can limit radiation damage to lungs and heart for cancer patients

ESTRO 2013: Commonly used drug can limit radiation damage to lungs and heart for cancer patients

Gene signature can predict who will survive chemotherapy

Gene signature can predict who will survive chemotherapy

More from ecancer